{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T01:10:25Z","timestamp":1709946625970},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1-4","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12029-008-9040-0","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T11:54:57Z","timestamp":1231847697000},"page":"114-117","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cholangiocarcinoma: Expanding the Spectrum of Risk Factors"],"prefix":"10.1007","volume":"39","author":[{"given":"Diaa H.","family":"Elfaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea A.","family":"Gossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"9040_CR1","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","volume":"341","author":"PC de Groen","year":"1999","unstructured":"de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368\u201378. doi:10.1056\/NEJM199910283411807.","journal-title":"N Engl J Med"},{"key":"9040_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","volume":"40","author":"YH Shaib","year":"2004","unstructured":"Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40:472\u20137. doi:10.1016\/j.jhep.2003.11.030.","journal-title":"J Hepatol"},{"key":"9040_CR3","first-page":"3637","volume":"22","author":"IA Mouzas","year":"2002","unstructured":"Mouzas IA, Dimoulios P, Vlachonikolis IG, Skordilis P, Zoras O, Kouroumalis E. Increasing incidence of cholangiocarcinoma in Crete 1992-2000. Anticancer Res 2002;22:3637\u201341.","journal-title":"Anticancer Res"},{"issue":"Suppl. 6","key":"9040_CR4","doi-asserted-by":"publisher","first-page":"VI1","DOI":"10.1136\/gut.51.suppl_6.vi1","volume":"51","author":"SA Khan","year":"2002","unstructured":"Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51(Suppl. 6):VI1\u2013VI9. doi:10.1136\/gut.51.suppl_6.vi1.","journal-title":"Gut"},{"issue":"1","key":"9040_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/hep.22310","volume":"48","author":"B Boris","year":"2008","unstructured":"Boris B, Gregory JG. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008;48(1):308\u201321. doi:10.1002\/hep.22310.","journal-title":"Hepatology"},{"key":"9040_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jnci\/djj234","volume":"98","author":"TM Welzel","year":"2006","unstructured":"Welzel TM, McGlynn KA, Hsing AW, O\u2019Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra-and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006;98:873\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"9040_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K Burak","year":"2004","unstructured":"Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004;99:523\u20136. doi:10.1111\/j.1572-0241.2004.04067.x.","journal-title":"Am J Gastroenterol"},{"key":"9040_CR8","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-04-3586","volume":"65","author":"A Jimeno","year":"2005","unstructured":"Jimeno A, Rubio-Viqueira B, Amador ML, Oppenheimer D, Bouraoud N, Kulesza P, et al. Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents. Cancer Res 2005;65:3003\u201310.","journal-title":"Cancer Res"},{"key":"9040_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/01.cad.0000217433.48870.37","volume":"17","author":"M Wiedmann","year":"2006","unstructured":"Wiedmann M, Feisthammel J, Bluthner T, Tannapfel A, Kamenz T, Kluge A, et al. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib. Anticancer Drugs 2006;17:783\u201395. doi:10.1097\/01.cad.0000217433.48870.37.","journal-title":"Anticancer Drugs"},{"key":"9040_CR10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/hep.20143","volume":"39","author":"Z Zhang","year":"2004","unstructured":"Zhang Z, Lai GH, Sirica AE. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation. Hepatology 2004;39:1028\u201337. doi:10.1002\/hep.20143.","journal-title":"Hepatology"},{"key":"9040_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/1535-7163.299.3.3","volume":"3","author":"T Wu","year":"2004","unstructured":"Wu T, Leng J, Han C, Demetris AJ. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Mol Cancer Ther 2004;3:299\u2013307.","journal-title":"Mol Cancer Ther"},{"key":"9040_CR12","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1038\/sj.onc.1202231","volume":"17","author":"K Date","year":"1998","unstructured":"Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF\/NK4) for hepatocyte growth factor. Oncogene 1998;17:3045\u201354. doi:10.1038\/sj.onc.1202231.","journal-title":"Oncogene"},{"key":"9040_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-2002-34507","volume":"22","author":"AE Sirica","year":"2002","unstructured":"Sirica AE, Lai GH, Endo K, Zhang Z, Yoon BI. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets. Semin Liver Dis 2002;22:303\u201313. doi:10.1055\/s-2002-34507.","journal-title":"Semin Liver Dis"},{"key":"9040_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000077991","volume":"66","author":"MJ Olnes","year":"2004","unstructured":"Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004;66:167\u201379. doi:10.1159\/000077991.","journal-title":"Oncology"},{"key":"9040_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/hep.21337","volume":"44","author":"NF LaRusso","year":"2006","unstructured":"LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006;44:746\u201364. doi:10.1002\/hep.21337.","journal-title":"Hepatology"},{"key":"9040_CR16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.1572-0241.2005.41526.x","volume":"100","author":"AA Gossard","year":"2005","unstructured":"Gossard AA, Angulo P, Lindor KD. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis. Am J Gastroenterol 2005;100:1330\u201333. doi:10.1111\/j.1572-0241.2005.41526.x.","journal-title":"Am J Gastroenterol"},{"key":"9040_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"L Edward","year":"2006","unstructured":"Edward L. Krawitt, Autoimmune Hepatitis. New Engl J Med 2006;354:54\u201366. doi:10.1056\/NEJMra050408.","journal-title":"New Engl J Med"},{"issue":"4","key":"9040_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.22441","volume":"48","author":"P Charatcharoenwitthaya","year":"2008","unstructured":"Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008;48(4):1106\u2013117. doi:10.1002\/hep.22441.","journal-title":"Hepatology"},{"key":"9040_CR19","first-page":"616","volume":"49","author":"CY Chen","year":"2002","unstructured":"Chen CY, Shiesh SC, Tsao HC, Lin XZ. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma- the influence of sampling time and hepatolithiasis. Hepatogastroenterology 2002;49:616\u201320.","journal-title":"Hepatogastroenterology"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-008-9040-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-008-9040-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-008-9040-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-008-9040-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:47:14Z","timestamp":1709945234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-008-9040-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":19,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9040"],"URL":"https:\/\/doi.org\/10.1007\/s12029-008-9040-0","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"26 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}